Metropolitan Life Insurance Company (MetLife)’s ICU Medical ICUI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-3,571
Closed -$848K 2450
2021
Q4
$848K Sell
3,571
-69
-2% -$16.1K 0.01% 1081
2021
Q3
$850K Sell
3,640
-93
-2% -$19.5K 0.01% 1085
2021
Q2
$768K Sell
3,733
-255
-6% -$52.5K 0.01% 1212
2021
Q1
$819K Buy
3,988
+195
+5% +$41.2K 0.01% 1092
2020
Q4
$814K Sell
3,793
-92
-2% -$17.8K 0.01% 1028
2020
Q3
$710K Sell
3,885
-182
-4% -$34.3K 0.01% 955
2020
Q2
$750K Sell
4,067
-1,322
-25% -$263K 0.01% 920
2020
Q1
$1.09M Sell
5,389
-291
-5% -$56K 0.02% 639
2019
Q4
$1.06M Buy
5,680
+26
+0.5% +$4.47K 0.02% 861
2019
Q3
$902K Buy
5,654
+135
+2% +$26.9K 0.02% 909
2019
Q2
$1.39M Sell
5,519
-1
-0% -$232 0.02% 698
2019
Q1
$1.32M Sell
5,520
-23
-0.4% -$5.51K 0.02% 715
2018
Q4
$1.27M Buy
5,543
+12
+0.2% +$2.96K 0.03% 667
2018
Q3
$1.56M Buy
5,531
+318
+6% +$93.1K 0.03% 660
2018
Q2
$1.53M Sell
5,213
-3,525
-40% -$963K 0.02% 683
2018
Q1
$2.21M Buy
8,738
+4,009
+85% +$942K 0.03% 473
2017
Q4
$1.02M Sell
4,729
-5,651
-54% -$1.14M 0.01% 874
2017
Q3
$1.93M Sell
10,380
-82
-0.8% -$14.3K 0.01% 949
2017
Q2
$1.8M Hold
10,462
0.01% 985
2017
Q1
$1.6M Hold
10,462
0.01% 1037
2016
Q4
$1.54M Sell
10,462
-191
-2% -$27.6K 0.01% 1067
2016
Q3
$1.35M Sell
10,653
-39
-0.4% -$4.7K 0.01% 1130
2016
Q2
$1.21M Buy
10,692
+428
+4% +$44.4K 0.01% 1152
2016
Q1
$1.07M Buy
10,264
+548
+6% +$52.4K 0.01% 1145
2015
Q4
$1.1M Hold
9,716
0.01% 1137
2015
Q3
$1.06M Hold
9,716
0.01% 1157
2015
Q2
$929K Sell
9,716
-381
-4% -$35.6K 0.01% 1337
2015
Q1
$940K Hold
10,097
0.01% 1224
2014
Q4
$827K Hold
10,097
0.01% 1457
2014
Q3
$648K Hold
10,097
﹤0.01% 1547
2014
Q2
$614K Hold
10,097
﹤0.01% 1686
2014
Q1
$605K Hold
10,097
﹤0.01% 1677
2013
Q4
$643K Hold
10,097
﹤0.01% 1629
2013
Q3
$686K Hold
10,097
0.01% 1539
2013
Q2
$728K Buy
+10,097
New +$668K 0.01% 1440

Other funds holding ICUI

Metropolitan Life Insurance Company (MetLife)'s ICUI Position: Q1 2022 in Review

Metropolitan Life Insurance Company (MetLife) sold out of ICU Medical (ICUI) in Q1 2022, closing a stake of 3,571 shares — an estimated $848K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in ICUI in Q2 2013 and held it in 35 quarters. The position peaked at $2.21M in Q1 2018. 295 funds tracked by Wall St. Rank hold ICUI as of Q1 2022.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining ICU Medical position as of Q1 2022 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 3,571 ICU Medical shares in Q1 2022, an estimated $848K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in ICU Medical in Q2 2013 and held it in 35 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s ICU Medical position peaked at $2.21M in Q1 2018.
  • 295 funds tracked by Wall St. Rank held ICU Medical as of Q1 2022.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2022, filed 12 May 2022.